{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:22:35Z","timestamp":1795058555837,"version":"4.10.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4353,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1046\/j.0022-202x.2003.22113.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T13:48:58Z","timestamp":1104155338000},"page":"51-60","source":"Crossref","is-referenced-by-count":118,"title":["In Psoriasis Lesional Skin the Type I Interferon Signaling Pathway Is Activated, Whereas Interferon-\u03b1 Sensitivity Is Unaltered"],"prefix":"10.1016","volume":"122","author":[{"given":"Leslie","family":"Van der fits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontine I.","family":"Van der wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol P.","family":"Prens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martie C.M.","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/1523-1747.ep12613492","article-title":"Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma","volume":"104","author":"Bonnekoh","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","article-title":"Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line","volume":"106","author":"Boukamp","year":"1988","journal-title":"J Cell Biol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/1523-1747.ep12289702","article-title":"Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss","volume":"108","author":"Carroll","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1096\/fasebj.14.3.565","article-title":"Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D","volume":"14","author":"Chen","year":"2000","journal-title":"FASEB J"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s004030100219","article-title":"A modified ex vivo skin organ culture system for functional studies","volume":"293","author":"Companjen","year":"2001","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0035","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000018447","article-title":"Psoriasis associated with HCV and exacerbated by interferon alpha: Complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis","volume":"201","author":"Erkek","year":"2000","journal-title":"Dermatology"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/43.1.7822763","article-title":"Expression of MxA protein in inflammatory dermatoses","volume":"43","author":"Fah","year":"1995","journal-title":"J Histochem Cytochem"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0050","first-page":"310","article-title":"Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: A case report and review of the literature","volume":"95","author":"Fukuyama","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0055","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2133.1991.tb04943.x","article-title":"Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis)","volume":"124","author":"Griffiths","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1074-7613(00)00064-9","article-title":"CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha\/beta signaling","volume":"13","author":"Hida","year":"2000","journal-title":"Immunity"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1096\/fasebj.13.3.495","article-title":"Psoriatic keratinocytes show reduced stat-1a and IRF activation in response to IFN-\u03b3","volume":"13","author":"Jackson","year":"1999","journal-title":"FASEB J"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00371788","article-title":"Keratin 17: A useful marker in anti-psoriatic therapies","volume":"283","author":"de Jong","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0075","doi-asserted-by":"crossref","first-page":"39765","DOI":"10.1074\/jbc.M102502200","article-title":"Interferon-kappa, a novel type I interferon expressed in human keratinocytes","volume":"276","author":"LaFleur","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/j.1460-2075.1990.tb08216.x","article-title":"Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3","volume":"9","author":"Levy","year":"1990","journal-title":"EMBO J"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF00455323","article-title":"In situ localization of interferons in psoriatic lesions","volume":"281","author":"Livden","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0049-0172(97)80005-4","article-title":"Hepatitis C virus infection and autoimmunity","volume":"26","author":"McMurray","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0095","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.169.9.4822","article-title":"Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system","volume":"169","author":"Nardelli","year":"2002","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0100","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archderm.135.9.1104","article-title":"The immunologic and genetic basis of psoriasis","volume":"135","author":"Nickoloff","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2340\/0001555573395","article-title":"Psoriasis exacerbation induced by interferon-alpha. Report of two cases","volume":"73","author":"Pauluzzi","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0110","first-page":"415","article-title":"Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C","volume":"15","author":"Pittau","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0115","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/1523-1747.ep12475275","article-title":"The autologous mixed epidermal cell\u2013T lymphocyte reaction is elevated in psoriasis: A crucial role for epidermal HLA-DR+\/CD1a- antigen-presenting cells","volume":"96","author":"Prens","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1464-5491.2001.00562.x","article-title":"Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C","volume":"18","author":"Recasens","year":"2001","journal-title":"Diabet Med"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0923-1811(94)90016-7","article-title":"The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin","volume":"7","author":"Rizova","year":"1994","journal-title":"J Dermatol Sci"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky's postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jir.1994.14.229","article-title":"The type I interferon system is locally activated in psoriatic lesions","volume":"14","author":"Schmid","year":"1994","journal-title":"J Interferon Res"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-4362.1994.tb01070.x","article-title":"IL-1 alpha-induced expression of ICAM-1 on cultured hyperproliferative keratinocytes: Suppression by antipsoriatic dimethyl-fumarate","volume":"33","author":"Sebok","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0150","first-page":"29","article-title":"The antipsoriatic dimethyl-fumarate suppresses interferon-gamma-induced ICAM-1 and HLA-DR expression on hyperproliferative keratinocytes. Quantification by a culture plate-directed APAAP-ELISA technique","volume":"8","author":"Sebok","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0155","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/107999099313325","article-title":"Immunomodulation and therapeutic effects of the oral use of interferon-alpha: Mechanism of action","volume":"19","author":"Tompkins","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0165","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI6910","article-title":"Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions","volume":"104","author":"Trepicchio","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02347624","article-title":"Development of Sj\u00f6gren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C","volume":"31","author":"Unoki","year":"1996","journal-title":"J Gastroenterol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/path.1263","article-title":"Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2)","volume":"199","author":"Van Der Fits","year":"2003","journal-title":"J Pathol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0180","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/MCB.12.8.3315","article-title":"Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins","volume":"12","author":"Veals","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<358::AID-PATH253>3.0.CO;2-8","article-title":"IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production","volume":"187","author":"Wei","year":"1999","journal-title":"J Pathol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0190","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202X.2003.22113.x_bb0195","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555575482483","article-title":"Psoriasis and hepatitis C virus","volume":"75","author":"Yamamoto","year":"1995","journal-title":"Acta Derm Venereol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15306011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15306011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T11:53:53Z","timestamp":1705492433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15306011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0022202X15306011"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2003.22113.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}